Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 7Recruiting 5Unknown 2Active not recruiting 2Withdrawn 1Terminated 1Enrolling by invitation 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Pancreatic Neoplasms 2

Interventions

Oxaliplatin 288Capecitabine 218Fluorouracil 213Irinotecan 146Leucovorin 140Gemcitabine 124S 1 (combination) 110apatinib 109Cisplatin 102Bevacizumab 99Drug Therapy 98Radiotherapy 97Paclitaxel 97camrelizumab 89sintilimab 79Cetuximab 75lenvatinib 62Neoadjuvant Therapy 61tislelizumab 55Surgical Procedures, Operative 54Sorafenib 53Folfox protocol 53toripalimab 52Docetaxel 52130-nm albumin-bound paclitaxel 47Laparoscopy 41HMPL-013 40XELOX 39Radiosurgery 36Albumin-Bound Paclitaxel 36

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Pancreatectomy × Gastrointestinal × Clear all
NCT02823678 2017-07-28

Pancreas Volume and Diabetes Status Following Pancreatectomy

Florida Hospital Tampa Bay Division

Unknown
100 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT02117895 2016-08-11

Left Celiac Plexus Resection for Pancreatic Cancer at the Body and Tail

Fudan University

Phase 3 Unknown
180 enrolled
Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡